VANCOUVER, British Columbia, Feb. 16, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Fifth Third Bancorp (NASDAQ:FITB), Sprint Nextel (NYSE:S), BioSante (NASDAQ:BPAX), American Capital (NASDAQ:ACAS), and ON Semiconductor (NASDAQ:ONNN).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Fifth Third Bancorp (NASDAQ:FITB): Fifth Third Bancorp (NASDAQ:FITB) has recently awarded first place in the Top 10 New Business Leaders category by United Way of Greater Cincinnati in their Top Companies 2011 report. Fifth Third Bancorp's Vantiv, LLC, formerly known as Fifth Third Processing Solutions, LLC, recently announced that Vantiv and Great Florida Bank have achieved a new multi-year contract. Under the contract, they will provide Merchant Bank payment acceptance solutions to their commercial banking customers. Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in FITB are starting to buy more company shares. See insider trade report for FITB here.
Read Full Report: http://www.Pennystocksinsiders.com/PR/021612B/FITB/FifthThirdBancorp.pdf
Sprint Nextel Corporation (NYSE:S): Sprint Nextel Corporation (NYSE:S) and The National Basketball Association will host the NBA All-Star E-Recycling Day at Orlando Festival Park on February 18. The companies will collaborate this year on a number of sustainability initiatives to educate and encourage fans to recycle and reduce their carbon footprint. In the past 52 weeks, Sprint Nextel share prices have been bracketed by a low of US$2.10 and a high of US$6.45, and are now at US$2.26, only 7% above that low price. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?
Read Full Report: http://www.Pennystocksinsiders.com/PR/021612B/S/SprintNextel.pdf
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX): BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) yesterday announced the approval of Bio-T-Gel by the U.S. Food and Drug Administration. On February 14, the company's President and CEO, Stephen M. Simes, will present a corporate update at the BIO CEO & Investor Conference. The stock yesterday soared 27.28% higher, moving up US$0.208 to US$0.969 per share. There were 52 million stock shares traded, which was 6.5 times more than average volume. BioSante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. Investors can reduce investment risk by checking insider trades in BPAX. See if CEOs, CFOs, and Directors in BPAX are trading the stock now.
Read Full Report: http://www.Pennystocksinsiders.com/PR/021612B/BPAX/BioSante.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
American Capital Ltd. (NASDAQ:ACAS):
Read Full Report: http://www.Pennystocksinsiders.com/PR/021612B/ACAS/AmericanCapital.pdf
ON Semiconductor Corp. (NASDAQ:ONNN):
Read Full Report: http://www.Pennystocksinsiders.com/PR/021612B/ONNN/ONSemiconductor.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.